CAT# | CPM-1-0139 |
Sequence | LLLLTVLTV |
Size | 50 Test, 100 Test | Antigen | Cancer | Epitope Origin | MUC1 | MHC Restriction | HLA-A_02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0347 | HLA-B_07_02 HIV gag tetramer-GPGHKARVL-BV421 labeled | Inquiry | ||
CPM-1-0464 | H-2Ld MCMV IE1 tetramer-YPHFMPTNL-PE labeled | Inquiry | ||
CPM-1-0080 | HLA-A_02_01 CD33 tetramer-AIISGDSPV-APC labeled | Inquiry | ||
CPM-1-0419 | HLA-A_02_01 p53 tetramer-SLPPPGTRV-BV421 labeled | Inquiry | ||
CPM-1-0643 | HLA-A_02_01 Adenovirus 11 Hexon914-922 tetramer-LLFEVFDVV-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Afamelanotide, a drug for tanning skin, is a synthetic peptide and analogue of α-melanocyte stimulating hormone. ...
C 21 is a kind of selective protein arginine methyltransferase 1 (PRMT1) inhibitor (IC50 = 1.8 μM). And it exhib ...
Secretin is a 27 amino acid polypeptide that is released during acidification in the duodenal cavity and stim ...
UFP-803 (H-Asp-c[Pen-Phe-DTrp-Dab-Tyr-Cys]-Val-OH), [Pen 5, DTrp 7, Dab 8] U-II (4-11), is a peptidic UT (urote ...
What is abaloparatide? Abaloparatide (formerly known as BA058) is an investigational analog of human PTHrP (1-34) being devel ...